Probiotic trials are frequently underpowered—not because sponsors ignore statistics, but because they underestimate how different probiotics are from conventional nutraceuticals. Unlike single-molecule ingredients, probiotics are living systems. Their ef Read More >>
Probiotic trials don’t fail only because a strain “doesn’t work.” Many fail because the endpoint doesn’t match the claim, the population, or the biology of a living product—and the study […] Read More >>
by Manushvi Chadha, BPharm, RA Cert Regulatory Affairs Associate, dicentra The past year had the NHPD re-evaluate their strategy for enzyme and probiotic-containing products, which had been on hold for […] Read More >>
Welcome Spring and Summer 2011 After a long cold winter it’s with extreme excitement that we welcome the spring and the coming summer. Spring always brings with it a feeling […] Read More >>
http://www.nutraingredients.com/ May 16, 2011 Omega-3 scientists oppose EFSA ALA claim An omega-3 researcher has written to the European Commission demanding a recent European Food Safety Authority (EFSA)-approved claim for omega-3 […] Read More >>
  This is Dicentra’s first newsletter for 2011. We will be releasing these newsletters every three months and the purpose of the newsletter is to keep our readers up to […] Read More >>
The Natural Health Products Directorate is requesting information from product license holders and applicants in light of the proposed amendments to the Food & Drug Regulations regarding enhanced labelling for […] Read More >>
  Executive Summary UPLAR Products in queue for over 180 days awaiting product licenses will now be issued ENs (exemption number) allowing the product to be legal for saleProducts must […] Read More >>